Overview

Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial

Status:
Completed

Trial end date:
2021-07-01

Target enrollment:

Participant gender:

Summary

This is an randomized controlled, multicenter clinical trial. The purpose of this study is to evaluate acute toxicity and efficacy of concurrent cisplatin chemoradiation with or without capecitabine as adjuvant chemotherapy in local advanced high risk nasopharyngeal carcinoma.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Zhao Chong

Collaborators:

Cancer Institute and Hospital, Chinese Academy of Medical Sciences
First People's Hospital of Foshan
Guangzhou General Hospital of Guangzhou Military Command
Jiangxi Provincial Cancer Hospital
National Cancer Centre, Singapore

Treatments:

Capecitabine
Cisplatin